FDA Class II drug recalls

What "Class II" means as a regulatory classification

Class II is the intermediate of the three classifications the FDA applies to drug recalls in its enforcement reports. Like the other tiers, it is the agency's categorisation of the recall event within its own regulatory framework — assigned by the FDA, recorded as a data field, and reproduced on this site exactly as the source states it. The label is administrative only. It is not a personalised measure of risk, not a clinical assessment, and not an instruction about how any individual should respond.

Class II covers a large share of routine recall actions, which makes this tier a useful lens for teams that monitor the steady flow of enforcement activity rather than only the highest-priority events. Quality-assurance specialists may scan Class II actions to understand the kinds of manufacturing, labelling or packaging issues that lead to mid-tier recalls; procurement and supply-chain teams may track them to anticipate disruptions. As always, indexing these records here is about retrieval and dating: every entry links to the verifiable openFDA source so the official report can be confirmed directly.

How to read the Class II list

The table below lists the Class II recall records currently in the indexed dataset, newest first by report date. Each row links to a dedicated record page presenting the product description, the recalling firm, the firm's stated reason for the recall, the distribution pattern, the geographic fields, and the relevant dates — all as regulatory data points taken from the enforcement report. Each record page links onward to the official openFDA query that returns the source.

The same cautions apply across every recall tier. A Class II entry records a regulatory action; it is an administrative fact rather than a clinical warning, and it says nothing about risk to a particular person. The list reflects the state of the data at the most recent ingestion, which can lag the live FDA record, so confirm the current status against the official source before relying on it.

What each Class II record contains

Each Class II record page presents the same set of regulatory fields taken from the FDA enforcement report. The recall number and event identifier connect the entry to the agency's systems and to related recall lines under the same event. The product description captures the item as characterised by the firm, and the recalling firm field names the company that conducted the action. The firm's stated reason is reproduced verbatim as a data field, presented only to help identify and verify the report rather than as guidance of any kind. The distribution pattern describes the reach of the product, the state and country fields locate the firm, and the report, initiation and termination dates place the action in time.

Because Class II covers so much routine enforcement activity, this consistent structure is especially useful for spotting patterns across many mid-tier actions — for instance, recurring labelling or packaging issues — without manually opening each report. The structure is purely organisational, however. It does not editorialise, score, or interpret. A Class II entry remains an administrative record of a regulatory action: it implies nothing about risk to a particular person and contains no clinical claim. The classification and every field value belong to the FDA; this page only surfaces them and links back to the verifiable source.

Related recall views

Class II sits between the agency's other recall tiers. You can also review Class I recalls and Class III recalls, or return to the drug recalls hub for the full definitions of recall classifications and statuses. The regulatory intelligence glossary defines the terminology, and the methodology and FDA data sources pages describe the data lineage.